Literature DB >> 19544382

Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia.

Kayo Terada1, Jun Yamada, Yoshinori Hayashi, Zhou Wu, Yasuo Uchiyama, Christoph Peters, Hiroshi Nakanishi.   

Abstract

Cathepsin B (CB) is a cysteine lysosomal protease implicated in a number of inflammatory diseases. Although it is now evident that caspase-1, an essential enzyme for maturation of interleukin-1beta (IL-1beta), can be activated through the inflammasome, there is still evidence suggesting the existence of lysosomal-proinflammatory caspase pathways. In the present study, a marked induction of pro-IL-1beta, its processing to the mature form and secretion were observed in the primary cultured microglia prepared from wild-type mice after stimulation with chromogranin A (CGA). Although pro-IL-1beta also markedly increased in microglia prepared from CB-deficient mice, CB-deficiency abrogated the pro-IL-1beta processing. CA-074Me, a specific inhibitor for CB, inhibited the pro-IL-1beta maturation and its release from microglia. Furthermore, the caspase-1 activation was also inhibited by CA-074Me and E-64d, a broad cysteine protease inhibitor. After treatment with CGA, CB was markedly induced at both protein and mRNA levels. The induced pro-CB was rapidly processed to its mature form. The immunoreactivity for CB co-localized with both that for caspase-1 and the cleaved IL-1beta, in the acidic enlarged lysosomes. Inconsistent with these in vitro observations, the immunoreactivity for the cleaved IL-1beta was markedly observed in microglia of the hippocampus from aged wild-type but not CB-deficient mice. These observations strongly suggest that CB plays a key role in the pro-IL-1beta maturation through the caspase-1 activation in enlarged lysosomes of CGA-treated microglia. Therefore, either pharmacological or genetic inhibition of CB may provide therapeutic intervention in inflammation-associated neurological diseases. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19544382     DOI: 10.1002/glia.20906

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  41 in total

1.  Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia.

Authors:  Richa Hanamsagar; Victor Torres; Tammy Kielian
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

2.  Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia.

Authors:  Shana E Terrill-Usery; Michael J Mohan; Michael R Nichols
Journal:  Biochim Biophys Acta       Date:  2014-08-11

3.  The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.

Authors:  Junjun Ni; Zhou Wu; Christoph Peterts; Kenji Yamamoto; Hong Qing; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

4.  Active cathepsins B, L, and S in murine and human pancreatitis.

Authors:  Victoria Lyo; Fiore Cattaruzza; Tyson N Kim; Austin W Walker; Margot Paulick; Daniel Cox; Jordan Cloyd; James Buxbaum; James Ostroff; Matthew Bogyo; Eileen F Grady; Nigel W Bunnett; Kimberly S Kirkwood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-16       Impact factor: 4.052

5.  Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain.

Authors:  Li Sun; Zhou Wu; Yoshinori Hayashi; Christoph Peters; Makoto Tsuda; Kazuhide Inoue; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

6.  Critical role for the AIM2 inflammasome during acute CNS bacterial infection.

Authors:  Richa Hanamsagar; Amy Aldrich; Tammy Kielian
Journal:  J Neurochem       Date:  2014-02-19       Impact factor: 5.372

Review 7.  Inflammasomes and their activation.

Authors:  Sonal Khare; Nancy Luc; Andrea Dorfleutner; Christian Stehlik
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

8.  Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes.

Authors:  Xiaoyou Shi; Liping Wang; Xiangqi Li; Peyman Sahbaie; Wade S Kingery; J David Clark
Journal:  Anesth Analg       Date:  2011-05-19       Impact factor: 5.108

9.  Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.

Authors:  Gregory Hook; Jin Yu; Thomas Toneff; Mark Kindy; Vivian Hook
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  Cathepsin B inhibition blocks neurite outgrowth in cultured neurons by regulating lysosomal trafficking and remodeling.

Authors:  Muzhou Jiang; Jie Meng; Fan Zeng; Hong Qing; Gregory Hook; Vivian Hook; Zhou Wu; Junjun Ni
Journal:  J Neurochem       Date:  2020-06-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.